Alzheimer Update

Alzheimers is a neurodegenerative disease. It's currently the 7th biggest killer of humans on this planet. After years of little progress on the treatment of this condition, there is now at least a glimmer of hope. Japanese pharmaceutical company, Eisai, and US Biotech, Biogen have developed an antibody treatment for Alzheimers (https://www.theguardian.com/society/2022/nov/22/treatment-for-alzheimers-lecanemab-dementia-research). The antibody treatment, lecanemab, has now been given to almost 2000 early onset Alzheimer patients. A press release (the study hasn't yet been published, so details are sparse), suggests that lecanemab slows cognitive decline in such individuals. If the data 'stands up', this will be the first treatment, benefiting early onset Alzheimers. Perhaps it will become a preventable condition?